How Drug Re-innovation Can Potentially Boost Pharma’s Depleting R&D Pipeline

The pharmaceutical industry’s typical R&D model of developing new chemical entities (NCEs) and creating ...

Best Practices for Forging Strategic Sponsor-CRO Relationships

A true strategic partnership has benefits for both the sponsor and the contract research ...

Reimagining Clinical Trial Registries

Since its launch in 2000, ClinicalTrials.gov has steadily grown in size and currently hosts ...

Clinical Research and the Challenge for Rare Diseases

Last year, I was unexpectedly thrust into the world of rare diseases. My sister, ...